Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for PMV Pharmaceuticals, Inc. COMMON STOCK (PMVP).
- Disclosed ownership: 9.4%.
- Date of event: 23 Oct 2025.
ORBIMED ADVISORS LLC - 23 Oct 2025 SCHEDULE 13D/A Report for PMV Pharmaceuticals, Inc. COMMON STOCK (PMVP)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Symbol
- PMVP
- Shares outstanding
- 52,928,628 shares
- Disclosed Ownership
- 4,975,291 shares
- Ownership
- 9.4%
- Form type
- SCHEDULE 13D/A
- Filing time
- 27 Oct 2025, 17:12:13 UTC
- Date of event
- 23 Oct 2025
- Next filing
- 04 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 9.4% ownership in PMV Pharmaceuticals, Inc. COMMON STOCK (PMVP) on 23 Oct 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Oct 2025, 17:12.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 9.4% | 4,975,291 | 0 | 4,975,291 | /s/ Carl L. Gordon | Carl L. Gordon / Member | 0001055951 |
| ORBIMED CAPITAL GP V LLC | 9.4% | 4,975,291 | 0 | 4,975,291 | /s/ Carl L. Gordon | Carl L. Gordon / Member of OrbiMed Advisors LLC | 0001615374 |